Suppr超能文献

慢性阻塞性肺疾病与代谢综合征:一项关于生物标志物及临床意义的马耳他研究

Chronic Obstructive Pulmonary Disease and Metabolic Syndrome: A Maltese Study on Biomarkers and Clinical Implications.

作者信息

Gauci Jonathan, Gauci Pullicino Stephanie, Caruana Emma, Petroni Magri Vanessa, Formosa Melissa Marie, Fenech Anthony G, Fava Stephen, Montefort Stephen, Fsadni Peter

机构信息

Department of Medicine, Mater Dei Hospital, Msida, Malta.

Department of Medicine, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.

出版信息

Diabetes Metab Syndr Obes. 2025 Jul 21;18:2463-2476. doi: 10.2147/DMSO.S515061. eCollection 2025.

Abstract

PURPOSE

Chronic Obstructive Pulmonary Disease (COPD) and Metabolic Syndrome (MetS) are both characterized by inflammation and appear to be linked. The study aims to characterize COPD in Maltese individuals with diabetes and MetS for the first time. The research project also aims to identify biomarkers that are significantly associated with COPD endpoints in the study population having both COPD and MetS.

PATIENTS AND METHODS

The study was carried out at Mater Dei Hospital, which is Malta's main general hospital and is government managed. Research subjects were recruited from the Diabetes Clinic. A respiratory questionnaire was administered, followed by the Six-Minute Walk Test (6MWT), Fractional Exhaled Nitric Oxide (FeNO) testing, spirometry and phlebotomy. The American Heart Association (AHA) and National Heart, Lung, and Blood Institute (NHLBI) criteria were used to diagnose MetS. A post-bronchodilator FEV/FVC ratio of less than 0.7 was necessary to diagnose COPD, as recommended by Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.

RESULTS

The study group consisted of 24 subjects diagnosed with both MetS and COPD. The group showed heterogenous results with a mean St George's Respiratory Questionnaire for COPD total score of 41.7, mean distance on 6MWT of 359m, mean FeNO of 12.2ppb, and mean Forced Expiratory Volume in 1 second of 64.6%. While 62.5% had a modified Medical Research Council score of ≥2, 95.8% had a COPD Assessment Test score of ≥10. One-fourth of the group were at risk for clinical depression, and 20.8% showed severe fatigue. Blood lymphocyte count, ferritin, triglycerides and glucose were significantly associated with multiple respiratory parameters in diabetic MetS subjects with COPD.

CONCLUSION

The local diabetic MetS study population with COPD is heterogenous, with high levels of depression and fatigue. The emergence of biomarkers in this population has clinical and therapeutic implications.

摘要

目的

慢性阻塞性肺疾病(COPD)和代谢综合征(MetS)均以炎症为特征,且似乎存在关联。本研究旨在首次对马耳他患有糖尿病和代谢综合征的个体中的COPD进行特征描述。该研究项目还旨在识别在同时患有COPD和MetS的研究人群中与COPD终点显著相关的生物标志物。

患者与方法

本研究在马耳他主要的公立医院、由政府管理的马特德伊医院开展。研究对象从糖尿病诊所招募。进行了一份呼吸问卷,随后进行六分钟步行试验(6MWT)、呼出一氧化氮分数(FeNO)检测、肺功能测定和静脉穿刺采血。采用美国心脏协会(AHA)和美国国立心肺血液研究所(NHLBI)的标准来诊断MetS。按照慢性阻塞性肺疾病全球倡议(GOLD)指南的建议,支气管扩张剂后FEV/FVC比值小于0.7是诊断COPD的必要条件。

结果

研究组由24名被诊断为同时患有MetS和COPD的受试者组成。该组结果具有异质性,COPD的圣乔治呼吸问卷总得分平均为41.7,6MWT平均距离为359米,FeNO平均为12.2ppb,一秒用力呼气量平均为64.6%。虽然62.5%的患者改良医学研究委员会评分≥2,但95.8%的患者COPD评估测试评分≥10。该组四分之一的患者有临床抑郁风险,20.8%的患者表现出严重疲劳。在患有COPD的糖尿病MetS受试者中,血液淋巴细胞计数、铁蛋白、甘油三酯和血糖与多个呼吸参数显著相关。

结论

当地患有COPD的糖尿病MetS研究人群具有异质性,存在高水平的抑郁和疲劳。该人群中生物标志物的出现具有临床和治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588f/12301145/f49141f24b63/DMSO-18-2463-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验